Trial Profile
The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies. A randomized, single-blind, placebo-control trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Lewy body disease
- Focus Therapeutic Use
- 08 Jun 2017 Results of post hoc analysis assessing effects of zonisamide on cognition and BPSD, presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 05 Aug 2016 Status changed from recruiting to completed.
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.